|
1
|
Bauer DC: HMG CoA reductase inhibitors and
the skeleton: A comprehensive review. Osteoporos Int. 14:273–282.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mundy G, Garrett R, Harris S, Chan J, Chen
D, Rossini G, Boyce B, Zhao M and Gutierrez G: Stimulation of bone
formation in vitro and in rodents by statins. Science.
286:1946–1949. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Meier CR, Schlienger RG, Kraenzlin ME,
Schlegel B and Jick H: HMG-CoA reductase inhibitors and the risk of
fractures. JAMA. 283:3205–3210. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang PS, Solomon DH, Mogun H and Avorn J:
HMG-CoA reductase inhibitors and the risk of hip fractures in
elderly patients. JAMA. 283:3211–3216. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu M, Wang K, Tang T, Dai K and Zhu Z:
The effect of simvastatin on the differentiation of marrow stromal
cells from aging rats. Pharmazie. 64:43–48. 2009.PubMed/NCBI
|
|
6
|
Song C, Guo Z, Ma Q, Chen Z, Liu Z, Jia H
and Dang G: Simvastatin induces osteoblastic differentiation and
inhibits adipocytic differentiation in mouse bone marrow stromal
cells. Biochem Biophys Res Commun. 308:458–462. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sugiyama M, Kodama T, Konishi K, Abe K,
Asami S and Oikawa S: Compactin and simvastatin, but not
pravastatin, induce bone morphogenetic protein-2 in human
osteosarcoma cells. Biochem Biophys Res Commun. 271:688–692. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Maeda T, Matsunuma A, Kawane T and
Horiuchi N: Simvastatin promotes osteoblast differentiation and
mineralization in MC3T3-E1 cells. Biochem Biophys Res Commun.
280:874–877. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Maeda T, Kawane T and Horiuchi N: Statins
augment vascular endothelial growth factor expression in
osteoblastic cells via inhibition of protein prenylation.
Endocrinology. 144:681–692. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Maeda T, Matsunuma A, Kurahashi I,
Yanagawa T, Yoshida H and Horiuchi N: Induction of osteoblast
differentiation indices by statins in MC3T3-E1 cells. J Cell
Biochem. 92:458–471. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Song QS, Wang JY, Leng HJ, Chen ZQ,
Liu ZJ, Dang GT and Song CL: Simvastatin induces estrogen
receptor-alpha expression in bone, restores bone loss, and
decreases ERα expression and uterine wet weight in ovariectomized
rats. J Bone Miner Metab. 29:396–403. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Maritz FJ, Conradie MM, Hulley PA, Gopal R
and Hough S: Effect of Statins on bone mineral density and bone
histomorphometry in rodents. Arterioscler Thromb Vasc Biol.
21:1636–1641. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Oxlund H and Andreassen TT: Simvastatin
treatment partially prevents ovariectomy-induced bone loss while
increasing cortical bone formation. Bone. 34:609–618. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Dai L, Xu M, Wu H, Xue L, Yuan D, Wang Y,
Shen Z, Zhao H and Hu M: The functional mechanism of simvastatin in
experimental osteoporosis. J Bone Miner Metab. 34:23–32. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ho ML, Chen YH, Liao HJ, Chen CH, Hung SH,
Lee MJ, Fu YC, Wang YH, Wang GJ and Chang JK: Simvastatin increases
osteoblasts and osteogenic proteins in ovariectomized rats. Eur J
Clin Invest. 39:296–303. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
von Stechow D, Fish S, Yahalom D, Bab I,
Chorev M, Müller R and Alexander JM: Does simvastatin stimulate
bone formation in vivo? BMC Musculoskelet Disord. 4:82003.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Pytlik M, Janiec W, Misiarz-Myrta M and
Gubała I: Effects of simavastatin on the development of osteopenia
caused by ovariectomy in rats. Pol J Pharmacol. 55:63–71.
2003.PubMed/NCBI
|
|
18
|
Yao W, Farmer R, Cooper R, Chmielewski PA,
Tian XY, Setterberg RB, Jee WS and Lundy MW: Simvastatin did not
prevent nor restore ovariectomy-induced bone loss in adult rats. J
Musculoskelet Neuronal Interact. 6:277–283. 2006.PubMed/NCBI
|
|
19
|
Rizzo M and Rini GB: Statins, fracture
risk, and bone remodeling: What is true? Am J Med Sci. 332:55–60.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Reginster JY and Burlet N: Osteoporosis: A
still increasing prevalence. Bone. 38(2): Suppl 1. S4–S9. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Canalis E, Giustina A and Bilezikian JP:
Mechanisms of anabolic therapies for osteoporosis. N Engl J Med.
357:905–916. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Thompson DD, Simmons HA, Pirie CM and Ke
HZ: FDA guidelines and animal models for osteoporosis. Bone. 17(4):
Suppl. S125–S133. 1995. View Article : Google Scholar
|
|
23
|
Kalu DN, Liu CC, Hardin RR and Hollis BW:
The aged rat madel of ovarian homone deficiency bone loss.
Endocrinology. 124:7–16. 1989. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jiang Y, Zhao J, Genant HK, Dequeker J and
Geusens P: Long-term changes in bone mineral and biomechanical
properties of vertebrae and femur in aging, dietary calcium
restricted, and/or estrogen-deprived/-replaced rats. J Bone Miner
Res. 12:820–831. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Food and Drug Administration (FDA), .
Draft Guidance for Industry and ReviewersEstimating the Safe
Starting Dose in Clinical Trials for Therapeutics in Adult Healthy
Volunteers. FDA; Rockville, MD: 2002
|
|
26
|
Food and Drug Administration (FDA), .
Guidance for IndustryFood-Effect Bioavailability and Fed
Bioequivalence Studies. FDA; Rockville, MD: 2002
|
|
27
|
Illingworth DR and Tobert JA: A review of
clinical trials comparing HMG-CoA reductase inhibitors. Clin Ther.
16:365–385. 1994.
|
|
28
|
Jee WS and Yao W: Overview: Animal models
of osteopenia and osteoporosis. J Musculoskel Neuron Interact.
1:193–207. 2001.
|
|
29
|
Gasser JA: Assessing bone quantity by
pQCT. Bone. 17(4): Suppl. S145–S154. 1995. View Article : Google Scholar
|
|
30
|
Ma YF, Ferretti JL, Capozza RF, Cointry G,
Alippi R, Zanchetta J and Jee WS: Effects of on/off anabolic hPTH
and remodeling inhibitors on metaphyseal bone of immobilized rat
femurs. Tomographical (pQCT) description and correlation with
histomorphometric changes in tibial cancellous bone. Bone. 17(4):
Suppl. S321–S327. 1995. View Article : Google Scholar
|
|
31
|
Ferretti JL, Capozza RF and Zanchetta JR:
Mechanical validation of a tomographic (pQCT) index for noninvasive
estimation of rat femur bending strength. Bone. 18:97–102. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Eriksson SA, Isberg BO and Lindgren JU:
Prediction of vertebral strength by dual photon absorptiometry and
quantitative computed tomography. Calcif Tissue Int. 44:243–250.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Fujita T, Fujii Y and Goto B: Measurement
of forearm bone in children by peripheral computed tomography.
Calcif Tissue Int. 64:34–39. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Quek ST and Peh WC: Radiology of
osteoporosis. Semin Musculoskelet Radiol. 6:197–206. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Turner CH: Biomechanics of bone:
Determinants of skeletal fragility and bone quality. Osteoporos In.
13:97–104. 2002. View Article : Google Scholar
|
|
36
|
Ferretti JL, Capozza RF, Mondelo N and
Zanchetta JR: Interrelationships between densitometric, geometric,
and mechanical properties of rat femora: Inferences concerning
mechanical regulation of bone modeling. J Bone Miner Res.
8:1389–1396. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Bauss F, Lalla S, Endele R and Hothorn LA:
Effects of treatment with ibandronate on bone mass, architecture,
biomechanical properties, and bone concentration of ibandronate in
ovariectomized aged rats. J Rheumatol. 29:2200–2208.
2002.PubMed/NCBI
|
|
38
|
Bouxsein ML and Seeman E: Quantifying the
material and structural determinants of bone strength. Best Pract
Res Clin Rheumatol. 23:741–753. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Nordin M and Frankel VH: Basic
Biomechanics of the Musculoskeletal System. 2nd. Lea & Febiger;
Philadelphia, PA: pp. 35–36. 1989
|
